No description availableRisk vs. reward: US panel narrowly recommends Merck’s COVID pillRead full article: Risk vs. reward: US panel narrowly recommends Merck’s COVID pillAn anti-COVID pill made by drugmaker Merck has been under review by officials, and on Wednesday its fate rested in the hands of the FDA.
